It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar.

Find out what's new from HealthXL - our latest industry report and a new community.

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar.

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines?‍

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines?‍

HealthXL and Almirall were lucky to have had a chance to run this event back in February in person in Barcelona prior to the COVID-19 escalation, and wish everybody in Spain and beyond well during these tough times. Below is a roundup of the discussions we had with some of the prominent leaders in

We looked at how companies interact with each other, and work together in different capacities depending on where along the digital health maturity journey they are.

This is your monthly digest of three noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.

This is your monthly digest of two noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.

We started our conversations on the digital opportunity for clinical trials at the HealthXL Global Gathering in September 2019. And after many months of exchanges, debates, and conversation, our long-awaited report on Clinical Trial Optimization is finally here! 

This is your monthly digest of three noteworthy news stories in digital health from the last few weeks - what they mean for the industry, and why you should know about them.

In January this year, we predicted the top trends in digital health for 2019. We suggested that clinical trials will go virtual and that digital biomarkers will become the norm. However, as we get closer to the end of the year, we can see that this is not a reality yet. How far is it from reality?

This is your monthly digest of three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy new stories from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines?

John Brownstein is the Chief Innovation Officer of Boston Children's Hospital. Boston Children’s Hospital is one of the first to use Alexa and voice technology in the homes of their patients. This discussion with John coincided with Alexa becoming HIPAA compliant.

This is your monthly digest of three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.

HealthXL collaborate with the American Medical Association (AMA) Physician Innovation Network (PIN). HealthXL members can now connect with peers, nationwide physicians and industry experts to validate their solutions.

This is your monthly digest of three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.

Chris Coburn, Partners Healthcare and an old friend of HealthXL talks to us about how growing up in a large healthcare family and the journey that led him to his current role as Chief Innovation Officer.

Eugene Borukhovich is disrupting healthcare! In this episode you will learn why, how and what is driving him. He unveils his thoughts on the American PBM model, on changing dynamics, innovative pharma companies, margins on digital health assets, his favorite start-ups and more!

A monthly digest of three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.

Our upcoming HealthXL Research report aims to identify, categorize, and summarize all existing, relevant studies in digital health. Through this report, we want to establish a clear understanding of the existing body of clinical evidence for digital health, its maturity, current gaps, and needs.

Three noteworthy news stories in digital health from the past month - what they mean for the industry, and why you should know about them.

Moving past investments in digital health, we are now starting to be asked about returns.What is the ROI on Digital Health? Return on investment (ROI) is king in every sector, healthcare not spared and we want to see finacial results.

Our report on Virtual Health Assistants (VHA). The report looks at the investment landscape, clinical evidence, and regulatory environment for VHAs, and also explores end-user feedback and case studies looking at both the positives and negatives of VHAs.

The Global Gathering hosted by Northwell Health welcomed over 80 attendees, convening over curated debates with from healthcare leaders. The event brought together members, collaborators, innovators & entrepreneurs. People with ideas, resources and desire to contribute to the evolution of healthcare

Few people trust their health insurance company. The numbers are unsurprising. According to a 2017 Revive Health survey 79% of consumers trust their doctors whilst only 69% reported trusting their insurers.This week we take a look at the emerging next gen payers.

The frenetic M&A activity in healthcare is rather disorienting and difficult to keep up with. We’ve rounded up the key themes we are seeing and what this may mean for all of us.

2018 was quite the year for M&A activity in healthcare. Some big announcements made waves such as the Amazon-PillPack, Roche-Flatiron, Cigna-Express Scripts, CVS-Aetna, ResMed-Propeller deals, there were hundreds of smaller ones too. We dig into what the ResMed - Propeller deal could mean for all.

The new wave in the industry is Digital Therapeutics (DTx). The term came into existence under the premise that mobile software can be effective medical treatments. DTx certainly seem to exhibit a superiority above all the 'banal' digital health solutions, but is the promise real?

In this week’s blog we are doing a round-up of our Global Gathering in Mumbai, discussing the digital health landscape in India and some of our key learnings from the event.

The FDA and European commission have taken some big steps as a response to the burgeoning digital health market, while still trying to fulfill its mission of protecting public health. In this blog, we look at American and European initiatives in putting some structure on the regulation of SaMDs.

Recap of HealthXL's Global Gathering in Menlo Park, hosted by GE Ventures. Highlighting the opioid crisis, solutions and removing the stigma. Also shining a light on how technology can enhance seniors living with dementia, by designing tools that address their needs and ability.

Is Alexa the new voice of healthcare delivery? She can give information about the weather, the news, play music, tell jokes, etc, surely she can solve your health woes, right? Maybe not just yet. Alexa won’t change healthcare delivery until she is HIPAA compliant.

Digital innovations that are unleashing the power of technology to fundamentally change how patient care is delivered in India. These innovations span across a wide range of areas such as telemedicine, appointment management, e-pharmacies and adherence tracking.

Scott Weiner MD, Assistant Professor of Emergency Medicine at Brigham and Women's Hospital who has spent many years researching and advocating for solutions to curb the opioid epidemic explains why he became interested in the topic, how hospitals can more effectively deal with this crisis.

We outline the stories of two very different humans whose paths cross given their relationship as patient and physician. You can see the problem of addiction and the hardships in treatment (even if very evidence-based) through their eyes.

Medical education needs a bit of shaking up, and medical schools are beginning to innovate to prepare new physicians for the emerging new model of care.

Digital therapeutics is at an inflection point in its hype cycle progression and has quickly begun to demonstrate its true potential as a solidified new category in healthcare today.

GDPR is set to place a greater responsibility on companies to actively engage with the people whose data they are processing, the healthcare industry will be impacted by a new paradigm on how privacy, personal information and consent are managed.

The United States is in the midst of the worst drug crisis in the nation’s history, a toll measured in fatalities on a scale never seen before. With a record-setting 42,000+ drug overdose deaths involving an opioid in 2016.